Table 2.
Lesion size and lesion disappearance (healing) at end of study in the efficacy population.
| Fitostimoline soaked gauzes | Fitostimoline cream | Catalase gel | Fitostimoline pooled | |
|---|---|---|---|---|
| Largest cross-diameter# | ||||
| mean (95% CI)a | 0.1 (0.0–0.5) | 0.4 (0.0–1.5) | 2.3 (0.3–5.9) | 0.2 (0.0–0.7) |
|
| ||||
| Surface area# | ||||
| mean (95% CI)a | 0.1 (0.0–0.3) | 0.2 (0.0–0.7) | 1.6 (0.1–4.5) | 0.1 (0.1–0.3) |
|
| ||||
| N (%) of values = 0 | 71 (97.3) | 65 (91.5) | 60 (84.5) | 136 (94.5) |
| N (%) of values > 0 | 2 (2.7) | 6 (8.5) | 11 (15.5) | 8 (5.5) |
|
| ||||
| Overall comparison among groups | P = .024* | |||
| Fitostimoline gauzes/cream | RR (95% CI)b 0.32 (0.066–1.51) | P = .16* | ||
| Fitostimoline pooled/Catalase gel | RR (95% CI)b 0.35 (0.15–0.84) | P = .020* | ||
#As percent ratio of baseline value.
aBack transformation of values calculated on angular-transformed data.
bRelative risk of not achieving lesion disappearance (size 0).
*Fisher's exact test.